Atlas Trials

Epithelial Sodium Channel (ENaC) as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes

Clinical trial NCT01804777 · TERMINATED

Trial details

NCT number
NCT01804777
Sponsor
University of New Mexico
Status
TERMINATED
Phase
Early Phase 1
Study type
INTERVENTIONAL
ProteinuriaHypertensionType II Diabetes
Start date
2013-03-01
Primary completion
2014-12-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.